Protagenic Therapeutics, Inc.\new Deferred Tax Assets, Operating Loss Carryforwards, Domestic
Protagenic Therapeutics, Inc.\new (PTIX) had Deferred Tax Assets, Operating Loss Carryforwards, Domestic of $5.95 million as of 2026-03-31, per its 10-K filed 2026-08-14.
Financial Statements › Notes › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic · last filed 2026-08-14
- 2026-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $5.95M.
- 2025-03-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $462.02K.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $6.30M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards, Domestic $4.94M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic as first filed |
|---|---|---|
| 2026-03-31 | $5.95M 10-K · filed 2026-08-14 | |
| 2025-03-31 | $462.02K 10-K · filed 2026-08-14 | |
| 2024-12-31 | $6.30M 10-K · filed 2025-03-31 | |
| 2023-12-31 | $4.94M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $3.62M 10-K/A · filed 2024-05-14 | |
| 2021-12-31 | $3.78M 10-K · filed 2023-03-31 | |
| 2020-12-31 | $2.91M 10-K · filed 2022-04-07 | |
| 2019-12-31 | $2.89M 10-K · filed 2021-03-25 | |
| 2018-12-31 | $2.63M 10-K · filed 2020-04-29 | |
| 2017-12-31 | $2.17M 10-K · filed 2019-03-29 | |
| 2016-12-31 | $1.90M 10-K · filed 2018-04-02 | $1.73M 10-K · filed 2017-04-18 |
| 2015-12-31 | $563.00K 10-K/A · filed 2017-05-08 | |
| 2014-12-31 | $401.00K 8-K/A · filed 2016-07-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |